Sponsor
Maryland Cigarette Restitution Fund
Clinical research sponsor
Clinical trials
12 shownGut Microbiome, Adverse Effects, and Markers Through MEtabolic ReprogrammingNCT06536881 · collaborator · 2024-08-08
RECRUITINGC-Raven LDCT: Lung Cancer Screening InterventionNCT07819318 · collaborator · 2026-10-15
NOT_YET_RECRUITINGC-Raven, a Virtual Tobacco Cessation Intervention in Residency ClinicsNCT07220356 · collaborator · 2025-12-10
ACTIVE_NOT_RECRUITINGStudy of Produce Prescription Programs in Adults With Overweight or Obesity Experiencing Nutrition InsecurityNCT06751563 · collaborator · 2025-01-08
COMPLETEDC-Raven, a Virtual Tobacco Cessation Intervention in the CommunityNCT06545669 · collaborator · 2024-10-30
COMPLETEDBehavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive InterventionsNCT06463249 · collaborator · 2024-06-17
ACTIVE_NOT_RECRUITINGTesting C-Raven, a Virtual Tobacco Cessation Intervention, in the CommunityNCT06289192 · collaborator · 2024-04-30
COMPLETEDBariatric Arterial Embolization for Men Starting Hormones for Prostate CancerNCT04331717 · collaborator · 2020-11-16
WITHDRAWNBehavioral Weight Loss Program for Cancer Survivors in MarylandNCT04534309 · collaborator · 2020-09-22
COMPLETEDEMPOWER Men to Reduce Weight and Inhibit Prostate Cancer ProgressionNCT04266431 · collaborator · 2020-02-20
COMPLETEDSurvivorship Promotion In Reducing IGF-1 TrialNCT02431676 · collaborator · 2015-05-01
COMPLETEDInpatient Screening Mammography for Non-adherent and High Risk WomenNCT04164251 · collaborator · 2015-01-01
COMPLETEDSponsor roles
collaborator12
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.